$BTAI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BioXcel Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BioXcel Therapeutics, Inc.. Get notifications about new insider transactions in BioXcel Therapeutics, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 29 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Option Exercise | A | 41.17 | 10,000 | 411,700 | 10,000 | |
Mar 29 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Option Exercise | A | 41.17 | 22,000 | 905,740 | 22,000 | |
Mar 29 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Option Exercise | A | 41.17 | 20,000 | 823,400 | 20,000 | |
Mar 29 2021 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President and ... | Option Exercise | A | 41.17 | 250,000 | 10,292,500 | 250,000 | |
Mar 18 2021 | BTAI | BioXcel Therapeuti ... | BioXcel Holdings, Inc. | 10% Owner | Sell | J | 60.76 | 160,000 | 9,721,600 | 0 | 160 K to 0 (-100.00 %) |
Mar 18 2021 | BTAI | BioXcel Therapeuti ... | BioXcel Holdings, Inc. | 10% Owner | Buy | J | 60.76 | 160,000 | 9,721,600 | 160,000 | 0 to 160 K |
Mar 18 2021 | BTAI | BioXcel Therapeuti ... | BioXcel Holdings, Inc. | 10% Owner | Sell | J | 60.76 | 160,000 | 9,721,600 | 9,020,000 | 9.2 M to 9 M (-1.74 %) |
Mar 18 2021 | BTAI | BioXcel Therapeuti ... | BioXcel LLC | 10% Owner | Sell | J | 60.76 | 160,000 | 9,721,600 | 9,020,000 | 9.2 M to 9 M (-1.74 %) |
Feb 24 2021 | BTAI | BioXcel Therapeuti ... | Rodriguez Javier | See Remarks | Option Exercise | A | 54.90 | 32,000 | 1,756,800 | 32,000 | |
Feb 19 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Option Exercise | M | 11.00 | 10,000 | 110,000 | 21,047 | |
Feb 19 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Option Exercise | M | 0.41 | 15,000 | 6,150 | 59,425 | |
Feb 19 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 57.17 | 600 | 34,302 | 0 | 600 to 0 (-100.00 %) |
Feb 19 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 56.60 | 9,573 | 541,832 | 600 | 10.2 K to 600 (-94.10 %) |
Feb 19 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 55.55 | 6,872 | 381,740 | 10,173 | 17 K to 10.2 K (-40.32 %) |
Feb 19 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 54.45 | 5,655 | 307,915 | 17,045 | 22.7 K to 17 K (-24.91 %) |
Feb 19 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 53.77 | 2,300 | 123,671 | 22,700 | 25 K to 22.7 K (-9.20 %) |
Feb 19 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Buy | M | 11.00 | 10,000 | 110,000 | 25,000 | 15 K to 25 K (+66.67 %) |
Feb 19 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Buy | M | 0.41 | 15,000 | 6,150 | 15,000 | 0 to 15 K |
Feb 18 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Sell | S | 61.20 | 600 | 36,720 | 73,397 | 74 K to 73.4 K (-0.81 %) |
Feb 18 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Sell | S | 60.43 | 1,772 | 107,082 | 73,997 | 75.8 K to 74 K (-2.34 %) |
Feb 18 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Sell | S | 59.46 | 500 | 29,730 | 75,769 | 76.3 K to 75.8 K (-0.66 %) |
Feb 18 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Sell | S | 58.54 | 2,886 | 168,946 | 76,269 | 79.2 K to 76.3 K (-3.65 %) |
Feb 18 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Sell | S | 57.71 | 1,137 | 65,616 | 79,155 | 80.3 K to 79.2 K (-1.42 %) |
Feb 18 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Sell | S | 56.49 | 6,805 | 384,414 | 80,292 | 87.1 K to 80.3 K (-7.81 %) |
Feb 18 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Sell | S | 55.88 | 1,300 | 72,644 | 87,097 | 88.4 K to 87.1 K (-1.47 %) |
Feb 03 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Option Exercise | M | 5.55 | 3,750 | 20,813 | 80,148 | |
Feb 03 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Sell | S | 48.15 | 3,750 | 180,563 | 1,500 | 5.3 K to 1.5 K (-71.43 %) |
Feb 03 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Buy | M | 5.55 | 3,750 | 20,813 | 5,250 | 1.5 K to 5.3 K (+250.00 %) |
Jan 27 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Option Exercise | M | 0.41 | 15,000 | 6,150 | 54,310 | |
Jan 27 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Sell | S | 49.35 | 4,107 | 202,680 | 88,397 | 92.5 K to 88.4 K (-4.44 %) |
Jan 27 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Sell | S | 48.39 | 6,521 | 315,551 | 92,504 | 99 K to 92.5 K (-6.59 %) |
Jan 27 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Sell | S | 47.62 | 3,472 | 165,337 | 99,025 | 102.5 K to 99 K (-3.39 %) |
Jan 27 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Sell | S | 46.94 | 900 | 42,246 | 102,497 | 103.4 K to 102.5 K (-0.87 %) |
Jan 27 2021 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Buy | M | 0.41 | 15,000 | 6,150 | 103,397 | 88.4 K to 103.4 K (+16.97 %) |
Jan 21 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Option Exercise | M | 0.41 | 25,000 | 10,250 | 74,425 | |
Jan 21 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 52.45 | 1,377 | 72,224 | 0 | 1.4 K to 0 (-100.00 %) |
Jan 21 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 51.45 | 1,500 | 77,175 | 1,377 | 2.9 K to 1.4 K (-52.14 %) |
Jan 21 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 50.38 | 2,700 | 136,026 | 2,877 | 5.6 K to 2.9 K (-48.41 %) |
Jan 21 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 49.27 | 12,665 | 624,005 | 5,577 | 18.2 K to 5.6 K (-69.43 %) |
Jan 21 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 48.43 | 6,758 | 327,290 | 18,242 | 25 K to 18.2 K (-27.03 %) |
Jan 21 2021 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Buy | M | 0.41 | 25,000 | 10,250 | 25,000 | 0 to 25 K |
Dec 30 2020 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Option Exercise | M | 0.41 | 25,000 | 10,250 | 99,425 | |
Dec 30 2020 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 53.54 | 1,353 | 72,440 | 0 | 1.4 K to 0 (-100.00 %) |
Dec 30 2020 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 52.68 | 3,951 | 208,139 | 1,353 | 5.3 K to 1.4 K (-74.49 %) |
Dec 30 2020 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 51.75 | 5,727 | 296,372 | 5,304 | 11 K to 5.3 K (-51.92 %) |
Dec 30 2020 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Sell | S | 50.77 | 13,969 | 709,206 | 11,031 | 25 K to 11 K (-55.88 %) |
Dec 30 2020 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Buy | M | 0.41 | 25,000 | 10,250 | 25,000 | 0 to 25 K |
Jun 23 2020 | BTAI | BioXcel Therapeuti ... | Benabou Reina | See Remarks | Option Exercise | A | 56.97 | 60,000 | 3,418,200 | 60,000 | |
Jun 17 2020 | BTAI | BioXcel Therapeuti ... | Kane William P Jr | Chief Commercial Of ... | Option Exercise | A | 52.82 | 110,000 | 5,810,200 | 110,000 | |
May 28 2020 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Option Exercise | A | 45.99 | 45,000 | 2,069,550 | 45,000 | |
May 28 2020 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Option Exercise | A | 45.99 | 55,000 | 2,529,450 | 55,000 | |
May 28 2020 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President and ... | Option Exercise | A | 45.99 | 250,000 | 11,497,500 | 250,000 | |
May 28 2020 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Option Exercise | A | 45.99 | 40,000 | 1,839,600 | 40,000 | |
May 26 2020 | BTAI | BioXcel Therapeuti ... | Laumas Sandeep | Director | Option Exercise | A | 49.74 | 20,000 | 994,800 | 20,000 | |
May 26 2020 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Option Exercise | A | 49.74 | 5,000 | 248,700 | 5,000 | |
May 26 2020 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Option Exercise | A | 49.74 | 20,000 | 994,800 | 20,000 | |
May 26 2020 | BTAI | BioXcel Therapeuti ... | Votruba Michal | Director | Option Exercise | J | 49.74 | 20,000 | 994,800 | 0 | |
May 26 2020 | BTAI | BioXcel Therapeuti ... | Votruba Michal | Director | Option Exercise | A | 49.74 | 20,000 | 994,800 | 20,000 | |
May 13 2020 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President and ... | Sell | D | 30.08 | 300,000 | 9,024,000 | 9,180,000 | 9.5 M to 9.2 M (-3.16 %) |
May 13 2020 | BTAI | BioXcel Therapeuti ... | Nandabalan Krishnan | Director | Sell | D | 30.08 | 300,000 | 9,024,000 | 9,180,000 | 9.5 M to 9.2 M (-3.16 %) |
Apr 28 2020 | BTAI | BioXcel Therapeuti ... | Nandabalan Krishnan | Director | Option Exercise | A | 13.60 | 15,000 | 204,000 | 15,000 | |
Apr 28 2020 | BTAI | BioXcel Therapeuti ... | Nandabalan Krishnan | Director | Option Exercise | A | 13.60 | 15,000 | 204,000 | 15,000 | |
Feb 19 2020 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Option Exercise | M | 0.41 | 80,000 | 32,800 | 69,310 | |
Feb 19 2020 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Buy | M | 0.41 | 80,000 | 32,800 | 88,397 | 8.4 K to 88.4 K (+952.72 %) |
Aug 26 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 9.34 | 1,554 | 14,514 | 168,320 | 166.8 K to 168.3 K (+0.93 %) |
Aug 23 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 8.83 | 6,646 | 58,684 | 166,766 | 160.1 K to 166.8 K (+4.15 %) |
Aug 23 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 8.42 | 1,800 | 15,156 | 160,120 | 158.3 K to 160.1 K (+1.14 %) |
Aug 19 2019 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President and ... | Buy | P | 8.89 | 974 | 8,659 | 9,957 | 9 K to 10 K (+10.84 %) |
Aug 16 2019 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President & Se ... | Buy | P | 8.67 | 2,625 | 22,759 | 8,983 | 6.4 K to 9 K (+41.29 %) |
Aug 16 2019 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President & Se ... | Buy | P | 8.44 | 358 | 3,022 | 6,358 | 6 K to 6.4 K (+5.97 %) |
Aug 16 2019 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President & Se ... | Buy | P | 8.67 | 2,625 | 22,759 | 8,983 | 6.4 K to 9 K (+41.29 %) |
Aug 16 2019 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President & Se ... | Buy | P | 8.44 | 358 | 3,022 | 6,358 | 6 K to 6.4 K (+5.97 %) |
Jun 19 2019 | BTAI | BioXcel Therapeuti ... | Votruba Michal | Director | Option Exercise | J | 10.04 | 4,700 | 47,188 | 0 | |
Jun 19 2019 | BTAI | BioXcel Therapeuti ... | Votruba Michal | Director | Option Exercise | A | 10.04 | 4,700 | 47,188 | 4,700 | |
May 28 2019 | BTAI | BioXcel Therapeuti ... | Laumas Sandeep | Director | Option Exercise | A | 10.04 | 14,700 | 147,588 | 14,700 | |
May 28 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Option Exercise | A | 10.04 | 14,700 | 147,588 | 14,700 | |
May 28 2019 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President and ... | Option Exercise | A | 10.04 | 187,700 | 1,884,508 | 187,700 | |
Mar 18 2019 | BTAI | BioXcel Therapeuti ... | Votruba Michal | Director | Option Exercise | D | 7.91 | 10,000 | 79,100 | 0 | |
Dec 14 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 4.50 | 100 | 450 | 5,000 | 4.9 K to 5 K (+2.04 %) |
Dec 14 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 4.49 | 400 | 1,796 | 4,900 | 4.5 K to 4.9 K (+8.89 %) |
Dec 14 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 4.48 | 500 | 2,240 | 4,500 | 4 K to 4.5 K (+12.50 %) |
Dec 14 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 4.32 | 200 | 864 | 4,000 | 3.8 K to 4 K (+5.26 %) |
Dec 14 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 4.27 | 800 | 3,416 | 3,800 | 3 K to 3.8 K (+26.67 %) |
Dec 07 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.01 | 6,905 | 34,594 | 158,320 | 151.4 K to 158.3 K (+4.56 %) |
Dec 07 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.00 | 495 | 2,475 | 151,415 | 150.9 K to 151.4 K (+0.33 %) |
Dec 07 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.01 | 100 | 501 | 150,920 | 150.8 K to 150.9 K (+0.07 %) |
Dec 07 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.00 | 1,295 | 6,475 | 150,820 | 149.5 K to 150.8 K (+0.87 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.15 | 2,062 | 10,619 | 149,525 | 147.5 K to 149.5 K (+1.40 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.13 | 200 | 1,026 | 147,463 | 147.3 K to 147.5 K (+0.14 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.12 | 344 | 1,761 | 147,263 | 146.9 K to 147.3 K (+0.23 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.11 | 325 | 1,661 | 146,919 | 146.6 K to 146.9 K (+0.22 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.09 | 1,076 | 5,477 | 146,594 | 145.5 K to 146.6 K (+0.74 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Buy | P | 5.20 | 450 | 2,339 | 1,850 | 1.4 K to 1.9 K (+32.14 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Buy | P | 5.23 | 450 | 2,353 | 1,400 | 950 to 1.4 K (+47.37 %) |
Dec 04 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 5.15 | 500 | 2,575 | 3,000 | 2.5 K to 3 K (+20.00 %) |
Dec 04 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 5.09 | 500 | 2,545 | 2,500 | 2 K to 2.5 K (+25.00 %) |
Dec 04 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 5.20 | 500 | 2,600 | 2,000 | 1.5 K to 2 K (+33.33 %) |
Dec 04 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 5.18 | 100 | 518 | 1,500 | 1.4 K to 1.5 K (+7.14 %) |
Dec 04 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 5.14 | 100 | 514 | 1,400 | 1.3 K to 1.4 K (+7.69 %) |
Dec 04 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 5.13 | 100 | 513 | 1,300 | 1.2 K to 1.3 K (+8.33 %) |
Dec 04 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 5.10 | 200 | 1,020 | 1,200 | 1,000 to 1.2 K (+20.00 %) |
Dec 04 2018 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Buy | P | 5.20 | 500 | 2,600 | 1,500 | 1,000 to 1.5 K (+50.00 %) |
Nov 30 2018 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Buy | P | 5.00 | 500 | 2,500 | 1,000 | 500 to 1,000 (+100.00 %) |
Nov 30 2018 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Buy | P | 5.20 | 450 | 2,340 | 950 | 500 to 950 (+90.00 %) |
Nov 30 2018 | BTAI | BioXcel Therapeuti ... | Nandabalan Krishnan | Director | Buy | P | 4.92 | 1,000 | 4,915 | 1,000 | 0 to 1,000 |
Nov 30 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 5.20 | 300 | 1,560 | 1,000 | 700 to 1,000 (+42.86 %) |
Nov 30 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 5.17 | 100 | 517 | 700 | 600 to 700 (+16.67 %) |
Nov 30 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 5.05 | 300 | 1,515 | 600 | 300 to 600 (+100.00 %) |
Nov 30 2018 | BTAI | BioXcel Therapeuti ... | Mehta Vimal | CEO, President, Sec ... | Buy | P | 5.04 | 300 | 1,512 | 300 | 0 to 300 |
Nov 30 2018 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Buy | P | 5.02 | 500 | 2,511 | 500 | 0 to 500 |
Nov 30 2018 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Buy | P | 5.00 | 500 | 2,500 | 500 | 0 to 500 |
Mar 13 2018 | BTAI | BioXcel Therapeuti ... | Laumas Sandeep | Director | Option Exercise | A | 11.00 | 37,209 | 409,299 | 124,188 | |
Mar 13 2018 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Option Exercise | A | 11.00 | 32,232 | 354,552 | 116,130 | |
Mar 13 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Option Exercise | A | 11.00 | 37,209 | 409,299 | 161,397 | |
Mar 13 2018 | BTAI | BioXcel Therapeuti ... | Yocca Frank | Chief Scientific Of ... | Option Exercise | A | 11.00 | 36,498 | 401,478 | 185,808 | |
Mar 13 2018 | BTAI | BioXcel Therapeuti ... | O'Neill Vincent | Chief Medical Offic ... | Option Exercise | A | 11.00 | 31,047 | 341,517 | 155,472 |
Page: 1